Rajiv K. Aggarwal
Expertise in
6
conditions

Dr. Rajiv K. Aggarwal

Neurology
Minneapolis Clinic Of Neurology Ltd - Burnsville
675 East Nicollet Boulevard, Suite 100, 
Burnsville, MN 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
Minneapolis Clinic Of Neurology Ltd - Burnsville
675 East Nicollet Boulevard, Suite 100, 
Burnsville, MN 

Overview

Rajiv Aggarwal is a Neurologist practicing medicine in Burnsville, Minnesota.

Dr. Aggarwal is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Migraine, Restless Legs Syndrome, Oppenheim Dystonia, and X-Linked Dystonia-Parkinsonism.

Dr. Aggarwal is board certified in 2002, American Board Of Psychiatry And Neurology,2011, Neurology, and Sleep Medicine. He is actively involved in clinical research, participating in 7 clinical trials. Dr. Aggarwal is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in WI

Board Certifications

2002
American Board Of Psychiatry And Neurology,2011
Neurology
Sleep Medicine

Hospital Affiliations

St Francis Regional Medical Center
M Health Fairview Southdale Hospital
M Health Fairview Ridges Hospital

Languages Spoken

English
Hindi
Punjabi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Minneapolis Clinic of Neurology Ltd - Burnsville
675 East Nicollet Boulevard, Suite 100, Burnsville, MN 55337

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

M Health Fairview Neurology Clinic Minneapolis

909 Fulton Street Southeast, Floor 3, 
Minneapolis, MN 
 (15.3 miles away)
612-626-6688
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jerrold Vitek is a Neurologist practicing medicine in Minneapolis, Minnesota. Dr. Vitek is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Vagotomy. Dr. Vitek is board certified in Neurology: American Board Of Psychiatry And Neurology, 1992. Dr. Vitek is currently accepting new patients.

Expertise in
41
conditions
Expertise in
41
conditions
Referral may be required

Park Nicollet Struthers Parkinson's Center

6701 Country Club Dr, 
Golden Valley, MN 
 (16.8 miles away)
952-993-5495
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am a board-certified neurologist and clinical geneticist with special interest in movement disorders, such as Parkinson's disease, Huntington's disease, hereditary ataxias and spastic paraplegias, as well as other neurogenetic disorders. I have served as the medical director of the Struthers Parkinson's Center since 2000. In addition to the care of patients and families with neurologic diseases, I am also involved in clinical research to develop better treatments for Parkinson's disease and Huntington's disease. I am interested in education for both patients and medical professionals. I currently serve as a clinical professor of neurology at the University of Minnesota. My other current regional and national professional activities are as follows: • Medical Advisor, Minnesota Chapter of the Huntington's Disease Society of America, 1992 – current • Chair, Scientific Advisory Board for the Spastic Paraplegia Foundation, 2003 – current • Member, Steering Committees for KINECT-HD and GENEPDAssociate Editor, Journal of Huntington’s Disease. Dr. Nance is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Huntington Disease, Movement Disorders, Parkinson's Disease, and Mcleod Neuroacanthocytosis Syndrome. Dr. Nance is board certified in American Board Of Med Genetics And Genomics-Clinical Genetics & Genomics and American Board Of Psych & Neuro-Neurology. Dr. Nance is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Noran Neurological Clinic, P.A.

3601 Minnesota Dr, Suite 200, 
Bloomington, MN 
 (8.1 miles away)
612-879-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Trusheim is a Neurologist practicing medicine in Bloomington, Minnesota. Dr. Trusheim is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Trusheim is board certified in American Board Of Psychiatry And Neurology,2011, Neurology, Sleep Medicine, and 1989. Dr. Trusheim is currently accepting new patients.

Frequently Asked Questions about Dr. Rajiv K. Aggarwal

How do I make an appointment with Dr. Rajiv K. Aggarwal?

You can book an appointment with Dr. Rajiv K. Aggarwal by calling their office at 952-435-8516. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rajiv K. Aggarwal a top-rated expert for Migraine?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rajiv K. Aggarwal is classified as an Advanced expert for Migraine, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rajiv K. Aggarwal specialize in?

While Dr. Rajiv K. Aggarwal is a Neurology, they have specific expertise in Migraine, Restless Legs Syndrome, and Oppenheim Dystonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Rajiv K. Aggarwal accept my insurance?

Dr. Rajiv K. Aggarwal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 952-435-8516 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Aggarwal's expertise for a condition
ConditionClose
      View All 39 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile